OA10659A - Process for preparing solid dosage forms of very low-dose drugs - Google Patents

Process for preparing solid dosage forms of very low-dose drugs Download PDF

Info

Publication number
OA10659A
OA10659A OA9800013A OA9800013A OA10659A OA 10659 A OA10659 A OA 10659A OA 9800013 A OA9800013 A OA 9800013A OA 9800013 A OA9800013 A OA 9800013A OA 10659 A OA10659 A OA 10659A
Authority
OA
OAPI
Prior art keywords
composition according
drug
carrier
pharmaceutical composition
daily dose
Prior art date
Application number
OA9800013A
Other languages
English (en)
Inventor
James Albert Napper
Karen Triona O'brien
Sultan James Manek
Rajinder Kumar
Julia Mary Loudon
Michael Sydney George Clark
Neil Mortimer
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9515624.6A external-priority patent/GB9515624D0/en
Priority claimed from GBGB9606684.0A external-priority patent/GB9606684D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of OA10659A publication Critical patent/OA10659A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
OA9800013A 1995-07-29 1998-01-28 Process for preparing solid dosage forms of very low-dose drugs OA10659A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9515624.6A GB9515624D0 (en) 1995-07-29 1995-07-29 Novel process
GBGB9606684.0A GB9606684D0 (en) 1996-03-29 1996-03-29 Novel process

Publications (1)

Publication Number Publication Date
OA10659A true OA10659A (en) 2002-09-18

Family

ID=26307485

Family Applications (1)

Application Number Title Priority Date Filing Date
OA9800013A OA10659A (en) 1995-07-29 1998-01-28 Process for preparing solid dosage forms of very low-dose drugs

Country Status (25)

Country Link
EP (1) EP0841902A2 (fr)
JP (1) JPH11510493A (fr)
KR (1) KR19990035972A (fr)
CN (1) CN1196677A (fr)
AP (1) AP858A (fr)
AR (1) AR004178A1 (fr)
AU (1) AU716961B2 (fr)
BG (1) BG102266A (fr)
BR (1) BR9609804A (fr)
CA (1) CA2228048A1 (fr)
CZ (1) CZ24798A3 (fr)
DZ (1) DZ2077A1 (fr)
EA (2) EA199901055A1 (fr)
HU (1) HUP9900521A3 (fr)
IL (1) IL122897A0 (fr)
MA (1) MA23953A1 (fr)
MX (1) MX9800809A (fr)
NO (1) NO980384L (fr)
NZ (1) NZ315632A (fr)
OA (1) OA10659A (fr)
PL (1) PL325242A1 (fr)
SK (1) SK11098A3 (fr)
TR (1) TR199800156T1 (fr)
UY (1) UY24297A1 (fr)
WO (1) WO1997004750A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9619074D0 (en) * 1996-09-12 1996-10-23 Smithkline Beecham Plc Composition
NZ505807A (en) 1998-03-11 2003-01-31 Smithkline Beecham Corp Controlled release oral dosage form containing [R-(Z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo [2.2.2]oct-3-yl)acetonitrile monohydrochloride; useful for the treatment or prophylaxis of dementia
FR2796840B1 (fr) * 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques Comprimes faiblement doses et procede de preparation
PT1591121E (pt) 2000-12-14 2009-07-20 Ortho Mcneil Janssen Pharm Processo para preparar produtos de hormona esteróide compreendendo um agente estabilizante na forma não cristalina
WO2005097076A2 (fr) * 2004-04-09 2005-10-20 Smithkline Beecham Corporation Produits pharmaceutiques a faibles doses
WO2026018154A1 (fr) 2024-07-16 2026-01-22 Syremis Therapeutics Ltd. Associations de sabcoméline et d'antagonistes muscariniques ne pénétrant pas dans le snc
WO2026018155A1 (fr) 2024-07-16 2026-01-22 Syremis Therapeutics Ltd. Combinaisons de sabcoméine avec des antagonistes muscariniques pénétrant dans le système nerveux non central à action prolongée

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4489026A (en) * 1982-09-07 1984-12-18 The Upjohn Company Process for preparing solid unit dosage forms of ultra-low dose drugs
JPS5970614A (ja) * 1982-10-14 1984-04-21 Asahi Chem Ind Co Ltd 微量主薬系湿式固形製剤方法
US4898736A (en) * 1988-03-09 1990-02-06 Merck & Co., Inc. Method for tablet preparation
ATE269330T1 (de) * 1989-04-13 2004-07-15 Beecham Group Plc Chemische verbindungen
ZA939565B (en) * 1993-12-21 1994-08-11 Applied Analytical Ind Inc Method for preparing low dose pharmaceutical products.

Also Published As

Publication number Publication date
NO980384L (no) 1998-03-26
EA199800179A1 (ru) 1998-10-29
AU6738496A (en) 1997-02-26
AR004178A1 (es) 1998-11-04
KR19990035972A (ko) 1999-05-25
CN1196677A (zh) 1998-10-21
WO1997004750A2 (fr) 1997-02-13
IL122897A0 (en) 1998-08-16
EP0841902A2 (fr) 1998-05-20
BG102266A (en) 1998-10-30
AP9801170A0 (en) 1998-01-31
WO1997004750A3 (fr) 1997-03-27
TR199800156T1 (xx) 1998-04-21
NZ315632A (en) 1999-11-29
CA2228048A1 (fr) 1997-02-13
DZ2077A1 (fr) 2002-07-22
EA000740B1 (ru) 2000-02-28
UY24297A1 (es) 1997-01-23
HUP9900521A3 (en) 2001-04-28
JPH11510493A (ja) 1999-09-14
NO980384D0 (no) 1998-01-28
SK11098A3 (en) 1998-07-08
CZ24798A3 (cs) 1998-06-17
PL325242A1 (en) 1998-07-06
EA199901055A1 (ru) 2000-06-26
HUP9900521A2 (hu) 1999-06-28
MX9800809A (es) 1998-04-30
AP858A (en) 2000-07-12
BR9609804A (pt) 1999-07-06
AU716961B2 (en) 2000-03-09
MA23953A1 (fr) 1997-04-01

Similar Documents

Publication Publication Date Title
JP4868695B2 (ja) 崩壊性が良好な経口製剤
US5211958A (en) Pharmaceutical composition and process for its preparation
EP0568577B1 (fr) Formule de medicament a administration orale pour le traitement des insuffisances en dopamine du systeme nerveux central
UA73078C2 (uk) Фармацевтичний препарат у вигляді таблеток на основі солі дихлорметилендифосфорної кислоти та силікатованої мікрокристалічної целюлози та спосіб його одержання
KR20010034573A (ko) 합성 천연 프로게스테론과 에스트라디올을 기초로 하는약학적 조성물과 그의 제조 방법
US20030129246A1 (en) Process for preparing solid dosage forms of very low-dose drugs
JP2010265329A (ja) ８−クロロ−６，１１−ジヒドロ−１１−（４−ピペリジリデン）−５Ｈ−ベンゾ［５，６］シクロヘプタ［１，２−ｂ］ピリジンの経口用組成物
CN102151247A (zh) 包含外消旋卡朵曲的干粉制剂
OA10659A (en) Process for preparing solid dosage forms of very low-dose drugs
TWI426913B (zh) 提昇水懸浮性之細粒劑
UA126702C2 (uk) Фармацевтична композиція, яка містить брекспіпразол
JP2004505917A (ja) 安定なペルゴリドメシラート及びその作成の方法
MXPA98000809A (en) Procedure to prepare forms of solid doses of very low dose of farm
US8062664B2 (en) Process for preparing formulations of lipid-regulating drugs
AU611740B2 (en) Pharmaceutical composition and process for its preparation
KR20030081027A (ko) 피복 고형 최면 제제
AU751607B2 (en) Method of treatment of dementia
CN114306247B (zh) 一种含利福喷汀药物组合物及其制备方法
JP2002138034A (ja) 苦味マスキングチュアブル錠およびその製造方法
RU2221565C2 (ru) Фармацевтическая композиция, обладающая противотуберкулезной активностью, и способ ее получения
KR101737058B1 (ko) 테모졸로미드를 포함하는 안정성이 개선된 약제학적 조성물 및 이의 제조방법
TR202014200A2 (tr) Soğuk alginliği tedavi̇si̇ i̇çi̇n i̇buprofen, psödoefedri̇n ve askorbi̇k asi̇t i̇çeren farmasöti̇k bi̇leşi̇mler
US20060177512A1 (en) Process for preparing formulations of lipid-regulating drugs
CS233217B1 (cs) Analgetický prípravok so zvýšenou rozpustnostou
HU191102B (en) Process for producing pharmaceutical compositions of regulated dissolution of the active agents containing water-soluble inorganic pharmacons